Items where authors include "Perrone, R.D."

Article

Devuyst, O. orcid.org/0000-0003-3744-4767, Ahn, C., Barten, T.R.M. et al. (24 more authors) (2025) KDIGO 2025 clinical practice guideline for the evaluation, management, and treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD). Kidney International, 107 (2). S1-S239. ISSN 0085-2538

Torres, V.E., Ahn, C., Barten, T.R.M. et al. (27 more authors) (2025) KDIGO 2025 clinical practice guideline for the evaluation, management, and treatment of autosomal dominant polycystic kidney disease (ADPKD): executive summary. Kidney International, 107 (2). pp. 234-254. ISSN 0085-2538

Perrone, R.D. orcid.org/0000-0002-4963-1132, Oberdhan, D. orcid.org/0000-0003-1034-9049, Ouyang, J. et al. (9 more authors) (2023) OVERTURE: A worldwide, prospective, observational study of disease characteristics in patients with ADPKD. Kidney International Reports, 8 (5). pp. 989-1001. ISSN 2468-0249

Gansevoort, R.T., Hariri, A., Minini, P. et al. (11 more authors) (2023) Venglustat, a novel glucosylceramide synthase inhibitor, in patients at risk of rapidly progressing ADPKD: primary results of a double-blind, placebo-controlled, phase 2/3 randomized clinical trial. American Journal of Kidney Diseases, 81 (5). 517-527.e1. ISSN 0272-6386

Perrone, R.D., Hariri, A., Minini, P. et al. (10 more authors) (2022) The STAGED-PKD 2-stage adaptive study with a patient enrichment strategy and treatment effect modeling for improved study design efficiency in patients with ADPKD. Kidney Medicine, 4 (10). 100538. ISSN 2590-0595

Senum, S.R., Li, Y.S.M., Benson, K.A. et al. (25 more authors) (2022) Monoallelic IFT140 pathogenic variants are an important cause of the autosomal dominant polycystic kidney-spectrum phenotype. The American Journal of Human Genetics, 109 (1). pp. 136-156. ISSN 0002-9297

Cho, Y., Tong, A., Craig, J.C. et al. (28 more authors) (2021) Establishing a core outcome set for autosomal dominant polycystic kidney disease : report of the Standardized Outcomes in Nephrology–Polycystic Kidney Disease (SONG-PKD) consensus workshop. American Journal of Kidney Diseases, 77 (2). pp. 255-263. ISSN 0272-6386

Cho, Y., Rangan, G., Logeman, C. et al. (25 more authors) (2020) Core outcome domains for trials in autosomal dominant polycystic kidney disease: An international Delphi survey. American Journal of Kidney Diseases, 76 (3). pp. 361-373. ISSN 0272-6386

Sautenet, B., Cho, Y., Gutman, T. et al. (15 more authors) (2020) Range and variability of outcomes reported in randomized trials conducted in patients with polycystic kidney disease: A systematic review. American Journal of Kidney Diseases, 76 (2). pp. 213-223. ISSN 0272-6386

Hopp, K. orcid.org/0000-0002-2420-2358, Cornec-Le Gall, E., Senum, S.R. orcid.org/0000-0002-5489-9117 et al. (17 more authors) (2020) Detection and characterization of mosaicism in autosomal dominant polycystic kidney disease. Kidney International, 97 (2). pp. 370-382. ISSN 0085-2538

Cho, Y., Sautenet, B., Gutman, T. orcid.org/0000-0002-6341-8725 et al. (26 more authors) (2019) Identifying patient-important outcomes in polycystic kidney disease: An international nominal group technique study. Nephrology, 24 (12). pp. 1214-1224. ISSN 1320-5358